Journal Reviews

Predicting bone scan positivity in non-metastatic CRPC

1 May 2016 | | Urologic Oncology | Disease-Free Survival, Metastasis, Mortality, Prostate Cancer, Prostatectomy, Prostate Specific Antigen

There is evidence that suggests that early treatment with chemotherapy, immunotherapy or hormone therapy leads to a better response in patients with asymptomatic metastatic castrate resistant prostate cancer (CRPC). This study aimed to predict bone scan positivity in patients with...